Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,414 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · derivative · entry 8 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,244 Underlying: Common Stock · 20,414 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 247,900 shares, became exercisable as follows: 165,200 of the shares subject to the option are initial shares ("Initial Shares") and 82,700 of the shares subject to the option are contingent shares ("Contingent Shares"). 23,600 of the Initial Shares vested on October 13, 2014, 35,400 of the Initial Shares vested on October 13, 2015 and an additional 2,950 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 15% of the Contingent Shares were deemed vested as of October 13, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following October 13, 2014, with 25% of the remaining 85% of Contingent Shares having vested on October 13, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 1,100 | $63.21 | $69,531.00 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · nonDerivative · entry 7 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $62.80 to $63.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 800 | $61.55 | $49,240.00 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · nonDerivative · entry 6 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $61.02 to $61.845. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 4,361 | $60.25 | $262,750.25 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · nonDerivative · entry 5 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $59.93 to $60.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 9,092 | $59.61 | $541,974.12 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · nonDerivative · entry 4 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,261 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $58.91 to $59.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 2,300 | $58.37 | $134,251.00 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · nonDerivative · entry 3 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,353 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $57.90 to $58.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 2,761 | $57.08 | $157,597.88 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · nonDerivative · entry 2 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,653 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $56.79 to $57.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:21 UTC |
Yoo StephenChief Medical Officer
|
Exercise / conversionCommon Stock | 20,414 | $0.85 | $17,351.90 |
DisclosureSEC source: 0001562180-18-004642 · primarydocument.xml · nonDerivative · entry 1 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,262 | $0.00 Strike: $12.74 | $0.00 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · derivative · entry 13 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,238 Underlying: Common Stock · 3,262 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F8 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $18.85 | $0.00 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · derivative · entry 12 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following May 24, 2017. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $49.45 | $0.00 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · derivative · entry 11 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 Underlying: Common Stock · 2,604 shares Expires 2028-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vests in 12 equal monthly installments following May 25, 2018. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
SaleCommon Stock | 600 | $63.53 | $38,118.00 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 6 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $63.34 to $64.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
SaleCommon Stock | 600 | $62.81 | $37,686.00 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 5 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $62.06 to $63.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
SaleCommon Stock | 10,916 | $60.26 | $657,798.16 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 4 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.685. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
Exercise / conversionCommon Stock | 3,262 | $12.74 | $41,557.88 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 3 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
Exercise / conversionCommon Stock | 6,250 | $18.85 | $117,812.50 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 2 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:26 UTC |
BESHAR LUKE MDirector
|
Exercise / conversionCommon Stock | 2,604 | $49.45 | $128,767.80 |
DisclosureSEC source: 0001562180-18-004643 · primarydocument.xml · nonDerivative · entry 1 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 21:19 UTC |
Simpson CurranSVP, Technical Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 32,882 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001562180-18-004631 · primarydocument.xml · derivative · entry 6 Simpson Curran · CIK 0001346164 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,101 Underlying: Common Stock · 32,882 shares Expires 2025-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 21:19 UTC |
Simpson CurranSVP, Technical Operations
|
SaleCommon Stock | 15,494 | $64.71 | $1,002,616.74 |
DisclosureSEC source: 0001562180-18-004631 · primarydocument.xml · nonDerivative · entry 5 Simpson Curran · CIK 0001346164 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,500 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $64.30 to $65.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 21:19 UTC |
Simpson CurranSVP, Technical Operations
|
SaleCommon Stock | 6,505 | $63.64 | $413,978.20 |
DisclosureSEC source: 0001562180-18-004631 · primarydocument.xml · nonDerivative · entry 4 Simpson Curran · CIK 0001346164 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,994 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $63.27 to $64.255. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 21:19 UTC |
Simpson CurranSVP, Technical Operations
|
SaleCommon Stock | 6,883 | $62.79 | $432,183.57 |
DisclosureSEC source: 0001562180-18-004631 · primarydocument.xml · nonDerivative · entry 3 Simpson Curran · CIK 0001346164 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,499 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $62.25 to $63.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 21:19 UTC |
Simpson CurranSVP, Technical Operations
|
SaleCommon Stock | 4,000 | $61.91 | $247,640.00 |
DisclosureSEC source: 0001562180-18-004631 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,382 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.21 to $62.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 21:19 UTC |
Simpson CurranSVP, Technical Operations
|
Exercise / conversionCommon Stock | 32,882 | $22.00 | $723,404.00 |
DisclosureSEC source: 0001562180-18-004631 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 16:16 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 100 | $64.10 | $6,410.00 |
DisclosureSEC source: 0001562180-18-004611 · primarydocument.xml · nonDerivative · entry 6 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,783 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 16:16 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 700 | $63.05 | $44,135.00 |
DisclosureSEC source: 0001562180-18-004611 · primarydocument.xml · nonDerivative · entry 5 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,883 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $62.81 to $63.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 16:16 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 2,042 | $62.23 | $127,073.66 |
DisclosureSEC source: 0001562180-18-004611 · primarydocument.xml · nonDerivative · entry 4 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,583 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $61.81 to $62.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 16:16 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 588 | $60.40 | $35,515.20 |
DisclosureSEC source: 0001562180-18-004611 · primarydocument.xml · nonDerivative · entry 3 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,625 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $59.98 to $60.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 16:16 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 1,900 | $59.06 | $112,214.00 |
DisclosureSEC source: 0001562180-18-004611 · primarydocument.xml · nonDerivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,213 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $58.81 to $59.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 16:16 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 2,170 | $58.46 | $126,858.20 |
DisclosureSEC source: 0001562180-18-004611 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,113 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $57.68 to $58.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 21:20 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 200 | $64.30 | $12,860.00 |
DisclosureSEC source: 0001562180-18-004532 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,000 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 21:20 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 6,214 | $63.65 | $395,521.10 |
DisclosureSEC source: 0001562180-18-004532 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,200 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $63.30 to $64.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 21:20 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 13,586 | $62.85 | $853,880.10 |
DisclosureSEC source: 0001562180-18-004532 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,414 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $62.29 to $63.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:20 UTC |
Christmas Patrick J.SVP, General Counsel
|
SaleCommon Stock | 15,000 | $72.06 | $1,080,900.00 |
DisclosureSEC source: 0001562180-18-004476 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,669 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $72.00 to $72.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 23:00 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 4,709 | $69.92 | $329,253.28 |
DisclosureSEC source: 0001562180-18-004451 · primarydocument.xml · nonDerivative · entry 5 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,000 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $69.80 to $70.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 23:00 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 3,340 | $69.47 | $232,029.80 |
DisclosureSEC source: 0001562180-18-004451 · primarydocument.xml · nonDerivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,709 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $68.80 to $69.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 23:00 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 3,635 | $68.27 | $248,161.45 |
DisclosureSEC source: 0001562180-18-004451 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,049 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $67.74 to $68.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 23:00 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 4,816 | $67.16 | $323,442.56 |
DisclosureSEC source: 0001562180-18-004451 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,684 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $66.73 to $67.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 23:00 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 3,500 | $66.29 | $232,015.00 |
DisclosureSEC source: 0001562180-18-004451 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,500 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $65.73 to $66.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:02 UTC |
Yoo StephenChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,414 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-18-004452 · primarydocument.xml · derivative · entry 7 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,658 Underlying: Common Stock · 20,414 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 247,900 shares, became exercisable as follows: 165,200 of the shares subject to the option are initial shares ("Initial Shares") and 82,700 of the shares subject to the option are contingent shares ("Contingent Shares"). 23,600 of the Initial Shares vested on October 13, 2014, 35,400 of the Initial Shares vested on October 13, 2015 and an additional 2,950 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 15% of the Contingent Shares were deemed vested as of October 13, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following October 13, 2014, with 25% of the remaining 85% of Contingent Shares having vested on October 13, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:02 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 4,627 | $69.97 | $323,751.19 |
DisclosureSEC source: 0001562180-18-004452 · primarydocument.xml · nonDerivative · entry 6 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $69.83 to $70.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:02 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 3,854 | $69.54 | $268,007.16 |
DisclosureSEC source: 0001562180-18-004452 · primarydocument.xml · nonDerivative · entry 5 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,627 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $68.83 to $69.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:02 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 3,700 | $68.22 | $252,414.00 |
DisclosureSEC source: 0001562180-18-004452 · primarydocument.xml · nonDerivative · entry 4 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,481 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $67.74 to $68.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:02 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 4,820 | $67.14 | $323,614.80 |
DisclosureSEC source: 0001562180-18-004452 · primarydocument.xml · nonDerivative · entry 3 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,181 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $66.73 to $67.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:02 UTC |
Yoo StephenChief Medical Officer
|
SaleCommon Stock | 3,413 | $66.26 | $226,145.38 |
DisclosureSEC source: 0001562180-18-004452 · primarydocument.xml · nonDerivative · entry 2 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,001 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $65.68 to $66.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:02 UTC |
Yoo StephenChief Medical Officer
|
Exercise / conversionCommon Stock | 20,414 | $0.85 | $17,351.90 |
DisclosureSEC source: 0001562180-18-004452 · primarydocument.xml · nonDerivative · entry 1 Yoo Stephen · CIK 0001652825 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,833 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001562180-18-004417 · primarydocument.xml · derivative · entry 10 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,167 Underlying: Common Stock · 20,833 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 50,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 32,908 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001562180-18-004417 · primarydocument.xml · derivative · entry 9 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,374 Underlying: Common Stock · 32,908 shares Expires 2026-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 75,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 16:20 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 53,741 | $70.26 | $3,775,842.66 |
DisclosureSEC source: 0001562180-18-004417 · primarydocument.xml · nonDerivative · entry 6 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,283 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionCommon Stock | 20,833 | $19.50 | $406,243.50 |
DisclosureSEC source: 0001562180-18-004417 · primarydocument.xml · nonDerivative · entry 5 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 16:20 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionCommon Stock | 32,908 | $13.09 | $430,765.72 |
DisclosureSEC source: 0001562180-18-004417 · primarydocument.xml · nonDerivative · entry 4 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.